Basic training in Regulatory Affairs
- 2° EDITION: 8-9 May 2025
- Online
Italian
- 1° EDITION: 13-15 November 2024
- 2° EDITION: 8-9 May 2025
- Online
-
Italiano
Training overview
Regulatory Affairs department plays a key role within pharmaceutical companies, interfacing with various business functions on a daily basis. Our Regulatory Affairs training course is dedicated to those who need to have an overview of this area because they are approaching a career in regulatory affairs or belong to other areas and need to improve their knowledge.
In fact, the purpose of the training course “Basic training in Regulatory Affairs” is to provide the fundamentals of key regulatory issues such as the preparation of the Quality Module and the procedural aspects governing the maintenance of the drug lifecycle.
Key points of the training
- Module I - CTD: understand and prepare the quality section (module 3)
- Module II - regulatory aspects of the lifecycle of a drug
09:30 – 12:30 MORNING SESSION
14:00 – 17:00 AFTERNOON SESSION
DAY 1 – Module I – CTD: understanding and preparing the Quality section (Module 3)
A) Regulatory References and Structure of CTD
- Regulatory agencies and ICH
- Structure of the CTD
- Documentary Setup of the CTD
B) Section 3.2.S “Drug substance”
- ASMF and CEP
- Review of the entire section
C) Section 3.2.P “Drug product”
- Review of the entire section
DAY 2 – Module II – Regulatory Aspects of the Lifecycle of a Drug
A) Drug registration procedures and variations
- Main legal and regulatory aspects
- Reference authorities in Italy and Europe – regulatory references
- Legal Basis
- The registration dossier according to product type and legal basis
- Overview of registration procedures (centralized, mutual recognition, decentralized, national)
B) Lifecycle Management
- Line extension
- Lifecycle: The EU variations regulation 712/2012
- Type I and Type II variations
- Preparation of a variation (cover letter,application form, front end, POL payment
- Printed matter: package leaflets, rcp, labels – QRD template – Procedures related to printed variations
- Disposal of stock and Farmastampati
- AIC renewals
- Sunset clause
Professionals involved in the pharmaceutical sector: Regulatory Affairs, Development Documentation, QA & Regulatory Compliance, Research & Development, Pharmacovigilance.
The course will be carried out through live lectures. Practical examples will be showcased, providing delegates with real life examples to be applied in their daily job life.
For online trainings the access link will be sent 2-3 days before the start of the training.
5% discount for registrations within 1 month before the start of the training, 10% discount for registrations within 2 months before the start of the training. VAT not included. Please inquire for discounts for multiple registrations. Discounts are not cumulative.
Cancellation terms
In order to cancel enrolment to an event, please email in**@*******************er.it within 2 weeks before the starting date of the event. Once this term will be expired, the entire fee will be charged.
Participant replacement
It is possible to replace a participant attendance without additional cost, simply by contacting in**@*******************er.it. It is asked to notify the participant replacement request within 5 days before the starting date of the course/event, specifying the full name and surname of the enrolled participant as well as the full name and surname of the substitute.
Training cancellation
If the minimum number of participants is not reached, Pharma Education Center reserves the right to cancel or schedule the event for another date. Formal communication will be given within 5 days before the event date. In this case Pharma Education Center will refund the registration fee in full and without additional charges. Alternatively, the participant can request a spendable coupon for participating in another PEC event scheduled in the current year.
Speakers
Raffaella Pandini
Italy Regulatory Affairs & Operations BU Director at Pharma D&S, a PLG Company
Graduated in 1997 in Pharmaceutical Chemistry and Technologies at the University of Milan, she gained professional experience in pharmaceutical companies and in the world of pharmaceutical consultancy. Pandini began her career in the regulatory affairs of Rottapharm srl and subsequently worked as RA Senior Officer at Zambon Group SPA. Since 2006 she has been Regulatory Affairs Director at PHARMA D&S and she is also involved in training activities within the Pharma Education Center.
ARE YOU INTERESTED IN REGULATORY AFFAIRS TRAININGS?
Enroll in 3 courses and you’ll get a 15% discount*, while choosing 5 courses will grant you a 20% discount*!
Choose among these titles:
- Preclinical studies in drug registration: focus on toxicology guidelines and CTD structure
- Drug Master File (DMF): Struttura e Ciclo di vita
- Drug Master File (DMF): l’applicazione delle linee guida scientifiche ICH nello sviluppo di un API
- Focus on the Module 5 of the Common Technical Document (CTD)
- Impact of variations on the site regulatory and compliance activities
- Skilful drafting of technical documentation
- Basic training in Regulatory Affairs
- Common Technical Document (CTD) module 3: focus on the most critical aspects
(*) discounts apply to the full prices of the courses and cannot be combined with other promotions. The promotion is limited to enrolling the same person in 3 or 5 courses selected from those offered.
Register now
1400€
Prices are for the entire training session; when purchasing individual days, the price will be reduced.
Training materials available for attendees
Certificate of attendance
Senior trainers with hands-on experience
You may also be interested in...
- 5-6 May 2025
- Online
- 9 Maggio 2025
- Online
- 14-15 Maggio 2025
- Online
- NEW
- 14 May 2025
- Online
- 26 May 2025
- Online
- 4 Giugno 2025
- Online
- NEW
- 5 June 2025
- Online
- 9 June 2025
- Online
- 9 Giugno 2025
- Online
- NEW
- 10-11 June 2025
- Online
- 16 June 2025 (tbc)
- Online
- NEW
- 18 June 2025
- Online
Investigational Medicinal Products, or IMPs, are defined as "a pharmaceutical form of an active ingredient or placebo that is tested [...]